Why investors are chasing US biotechs with Chinese characteristics (opens in new tab)

On the surface Kailera Therapeutics is another US biotech start-up, with a Nasdaq listing and headquarters in Waltham, Massachusetts, a leafy Boston suburb and industry hub. But it got its start a world away in China, where its portfolio of weight-loss drugs was developed by Shanghai-based Hengrui Pharma, the country’s largest drugmaker by market value. […] The post Why investors are chasing US biotechs with Chinese characteristics appeared first on OODAloop.